Compare Medpace Holdings Inc (MEDP) vs Paycom Software Inc (PAYC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Paycom Software Inc — how do they compare? Medpace Holdings Inc trades at $597.39 (market cap $16.90B), while Paycom Software Inc trades at $211 (market cap $9.57B). The key difference: Medpace Holdings Inc is the larger of the two by market cap, and Paycom Software Inc pays a 0.71% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | PAYC | |
|---|---|---|
Market Cap | $16.90B | $9.57B |
Sector | Technology | Technology |
52-Week High | $620.59 | $233.89 |
52-Week Low | $393.42 | $113.59 |
Enterprise Value | $16.52B | $10.35B |
Dividend Yield | — | 0.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $596.98, down 0.9% on the day but near its 52-week highs. The stock shows strong technical momentum with bullish moving averages and recent golden cross formation. Fundamentally, the company delivered three consecutive quarterly earnings beats with Q2 2026 EPS of $4.25 beating expectations of $3.98. Revenue growth remains robust at 17.2% year-over-year in Q2 2026, supported by record net bookings and a $3.0 billion backlog.
MEDP presents a growth story with strong fundamentals but trades at premium valuations (P/E 35.58, P/S 6.27). The primary investment opportunity lies in continued execution on record bookings and backlog conversion. Key risks include the ongoing shareholder litigation investigation and potential valuation compression if growth moderates. Analyst consensus targets $599.57 with 21% buy ratings, suggesting limited near-term upside from current levels.
Paycom Software (PAYC) trades at $211.28, down 1.02% today, with a bullish technical outlook per moving averages but overbought RSI signals. The company reported strong Q2 2026 results, beating EPS estimates with $2.78 versus $2.38 expected, and raised its full-year revenue and EBITDA guidance, driven by AI-driven demand and operational efficiency.
The stock offers growth potential from robust earnings momentum and high profitability margins, but risks include valuation premiums and competitive pressures. Analyst consensus is mixed with a $219.22 price target, suggesting moderate upside from current levels amid near-term volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Paycom Software Inc
Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →
